Advanced Life Sciences, Inc, is a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs in the areas of infectious disease, inflammation and oncology. Using its internal discovery capabilities and the network of pharmaceutical and academic partners, it has assembled a promising pipeline of clinical and preclinical product candidates for the treatment of respiratory tract infections, human immunodeficiency virus, acute respiratory distress syndrome and cancer.

Adolor Corporation is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. It has more than 150 employees working in areas including discovery research, drug development, clinical research, manufacturing, business development and marketing. Adolor was founded to capitalize on emerging proprietary development in cloned opioid receptors and continues today as a leader in the discovery and development of novel opioid receptor-targeted therapeutics.

Adeza Biomedical Corporation is a medical technology company located in Sunnyvale, California. Adeza’s products are recognized worldwide through both direct sales and distribution in over 20 countries. Adeza’s product focus is on proprietary tests and services for the diagnosis of pregnancy-related and female reproductive disorders including premature birth and infertility.

Acusphere, Inc. is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary porous microparticle technology. It is focused on developing proprietary drugs that can offer significant benefits such as improved safety and efficacy, increased patient compliance, greater ease of use, expanded indications or reduced cost.

Acambis is a biotechnology company discovering, developing and manufacturing novel vaccines to prevent and treat infectious diseases. Recognised internationally as the leading producer of smallpox vaccines, Acambis is developing a second-generation smallpox vaccine that is currently undergoing clinical trials and is manufacturing emergency-use stockpiles of this investigational vaccine for the US Government and other governments around the world.

ZymoGenetics is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic proteins for the prevention or treatment of human diseases. The Company is developing a diverse pipeline of potential proprietary product candidates that are moving into and through clinical development. These span a wide array of clinical opportunities that include bleeding, autoimmune diseases and cancer. ZymoGenetics intends to commercialize these product candidates through internal development, collaborations with partners, and out-licensing of patents from its extensive patent portfolio.

Acadia Pharmaceuticals is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. It currently has five drug programs in clinical and preclinical development directed at large unmet medical needs and major commercial markets.

Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes biotherapeutics for significant unmet medical needs. A considerable number of the currently approved biotechnology products originated from or are based on Genentech science. Genentech manufactures and commercializes multiple biotechnology products and licenses several additional products to other companies.

Aastrom Biosciences, Inc. is developing patient-specific products for the repair or regeneration of human tissues, utilizing the Company’s proprietary adult stem cell technology. Aastrom’s strategic position in the tissue regeneration sector is enabled by its proprietary Tissue Repair Cells(TRCs), a mix of bone marrow-derived adult stem and progenitor cells, and the AastromReplicell System, an industry-unique automated cell production platform used to produce cells for clinical use. TRCs are the core component of the products Aastrom is developing for severe bone fractures, ischemic vascular disease, jaw reconstruction and spine fusion, with Phase I/II level clinical trials active in the U.S. and EU for some of these indications.

Ivax Corporation is a multinational company engaged in the research, development, manufacturing and marketing of branded and generic pharmaceuticals and veterinary products in the U.S. and internationally. It is headquartered in Miami, Florida, has direct operations in 39 countries, and markets products in more than 80 countries around the globe.

Sepracor Inc. is a research-based pharmaceutical company dedicated to treating and preventing human disease through the discovery, development, and commercialization of innovative pharmaceutical products that are directed toward serving unmet medical needs.

Ranbaxy Laboratories Limited, headquartered in India, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. It is ranked amongst the top ten generic companies worldwide.

CSL Limited is a global, specialty biopharmaceutical company that develops, manufactures and markets products to treat and prevent serious human medical conditions. Headquartered in Melbourne Australia, the CSL Group includes CSL Bioplasma, CSL Pharmaceutical and ZLB Behring incorporating ZLB Plasma Services.

Chiron is a multi-dimensional company with businesses in biopharmaceuticals, vaccines and blood testing. By developing new products, exploring new indications for existing products and expanding its market reach, Chiron will continue to bring improvement to health around the globe.

Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing.

Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum—from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing—Beckman Coulter’s 200,000 installed systems provide essential biomedical information to enhance health care around the world.

Biogen Idec Inc., a global biotechnology leader with leading products and capabilities in oncology, neurology and immunology, is committed to transforming scientific discovery into advances in healthcare. The company’s core capabilities include drug discovery, research, development, biomanufacturing, and a global commercial infrastructure.

Genzyme Corporation operates as a biotechnology company. Its products and services focuses on rare genetic disorders, renal disease, kidney disease, cancer, orthopaedics, organ transplant, and diagnostic and predictive testing.

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

Altana Pharma is a research-based company with dynamic growth. It employs some 8,200 people group-wide at locations in Europe, North and Latin America, South Africa, Asia and Australia. It researches, produces and markets medications in its core business of prescription medicines. It also manufactures and markets diagnostic products for imaging technologies and self-medication products which are available without prescription.

UCB is a world class biopharmaceutical publicly traded company, listed on Euronext Brussels. Created in 1928 by the merger of 13 factories manufacturing various intermediate chemicals, UCB has transformed itself over recent decades from a world leader pharmaceutical and chemical specialties company into a pure biopharmaceutical major leader; specialising in the fields of central nervous system disorders, allergy and respiratory diseases, immune and inflammatory disorders and oncology. UCB employs over 8,300 people operating in over 100 countries. In addition, UCB is represented through its agents, distributors and licensees and its products are sold Worldwide.

Serono is a global biotechnology leader and a developer of recombinant prescription medicines. It offers the world’s fastest growing multiple sclerosis therapy and is the world leader in infertility treatment. It offers the only growth hormone approved for the treatment of HIV-associated wasting and the only needle-free growth hormone delivery system, available with both our pediatric growth and HIV-associated wasting therapies.

Celesio is the absolute European leader in terms of the distribution of pharmaceutical products (to pharmacies and the hospital sector), backed up by indisputable expertise in logistics, in a profession where pharmacists may expect deliveries up to five time a day.Thus Celesio is working in 11 European countries and is particularly active in Great Britain, France, Germany and Austria. Not content with the packaging, transport and delivery of products, it also has its own chain of pharmacies (Lloyd’s, the British leader, Norsk Medicinal in Norway) among others. Its efficiency confirmed, Celesio is today venturing into B2B e-business.

Takeda is a research-based global company with its main focus on pharmaceuticals. It is the largest pharmaceutical company in Japan and among the leaders in the world. Takeda discovers, develops, manufactures and markets a broad range of superior pharmaceutical products to strive toward better health for individuals and progress in medicine.

Avestha Gengraine Technologies Pvt. Ltd. is India’s leading fully-integrated biotechnology & bioinformatics company, focusing on the convergence between food, pharma and clinical genomics leading to preventive personalized medicine. Avesthagen provides innovative solutions for global challenges in agriculture & health problems in the areas of degenerative conditions, metabolic disorders and infectious diseases.

Dr. Reddy’s Laboratories is an emerging, global pharmaceutical company with proven research capabilities. The company is focused on creating and delivering innovative and quality products to help people lead healthier lives.

Our technologies and expertise in the development and manufacture of quality organic intermediates, bulk actives (API) and finished dosage forms have been critical to our success in delivering innovative and affordable life-saving medicines to customers world-wide.

Biocon is India’s leading biotechnology enterprise. Over the past 25 years, it has evolved from an enzyme manufacturing company to a fully integrated biopharmaceutical enterprise, focused on healthcare. It applies the proprietary fermentation technologies to develop innovative and effective biomolecules in diabetology, oncology, cardiology and other therapeutic segments.

At Biocon, the success has been the ability to develop innovative technologies and products and to rapidly leverage them to adjacent domains. This unique “integrated innovation” approach has yielded a host of patented products and technologies that have enabled multi-level relationships with all the global clientele.

When Amgen was founded in 1980, the company consisted of a few scientists working on a single lab bench in one building. Today, it is the world’s largest biotechnology company, with approximately 14,000 staff members worldwide.

Amgen has pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry’s first blockbusters. Amgen is widely recognized as a top employer, having been included on Fortune Magazine’s “100 Best Places to Work” list and named in The Scientist’s annual survey of the best workplaces for scientists in 2004.

Eli Lilly and Company is one of the world’s largest research based pharmaceutical companies dedicated to creating and delivering innovative pharmaceutical health care solutions that enable people to live longer, healthier and more active lives.

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines in over 20 therapeutic categories. The company also devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service.

The mission of Merck is to provide society with superior products and services by developing innovations and solutions that improve the quality of life and satisfy customer needs, and to provide employees with meaningful work and advancement opportunities, and investors with a superior rate of return.

GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today’s rapidly changing healthcare environment.Headquartered in the UK and with operations based in the US, the new company is one of the industry leaders, with an estimated seven per cent of the world’s pharmaceutical market.

GSK also has leadership in four major therapeutic areas - anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. In addition, it is a leader in the important area of vaccines and has a growing portfolio of oncology products.